Krishnan Mahesh
SEC insider (Form 3/4/5 filer). CIK 0001866746. Director at HALOZYME THERAPEUTICS, INC. (HALO). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in SAN DIEGO, CA.
Companies Krishnan Mahesh has filed insider reports for
- HALOZYME THERAPEUTICS, INC. (HALO): Director
Krishnan Mahesh
CIK: 0001866746
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HALO
HALOZYME THERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 29, 2026HALO
HALOZYME THERAPEUTICS, INC.
ExerciseDirect7.3K shares at avg. $38.46$281K - Jun 29, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect7.3K shares at avg. $75.00$548K - May 5, 2026HALO
HALOZYME THERAPEUTICS, INC.
AwardDirect3.8K shares- - May 1, 2025HALO
HALOZYME THERAPEUTICS, INC.
AwardDirect4.2K shares-
1-4 of 4 transactions